NCT04705168Completed
Study of the Nevisense Device to Assess Atypical Skin Lesions
Performance of Nevisense Electrical Impedance Spectroscopy in Patients With Multiple Nevi and Large Acquired Nevi (LAN)
Source: ClinicalTrials.gov · Last updated 20 Nov 2025
Brief summary (registry, in English)
The purpose of this study is to find out whether the Nevisense device can provide useful information about atypical moles to complement the usual assessments done during routine screening for melanoma. Assessing particpants' moles with the Nevisense device may help improve screening methods for the early detection of melanoma in people with atypical mole syndrome.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 40 (actual)
- First submitted
- 8 Jan 2021
- Start date
- 8 Jan 2021
- Primary completion date
- 18 Nov 2025
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- NCT number
- NCT04705168
What you commit to
- Study type: Observational
- Participants enrolled: 40
- From 8 Jan 2021 to the primary completion date, 18 Nov 2025
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients without at least three clinically stable nevi between 5 and 20 mm in diameter.
- Patients with any electronic implantable devices.
- Patients who are pregnant (verbally confirmed with the participant).
Who the study is looking for
- Adult patients (\> 30 years of age) at the time of the initial study visit.
- Patients displaying a phenotype that consists of ≥ 100 nevi on the entire cutaneous surface and at least three large acquired nevi (LAN) \> 5 mm in diameter. These patients have "atypical mole syndrome", which is a high-risk nevus phenotype and the target patient population in this study.
- Patients with at least three clinically stable nevi between 5 and 20 mm in diameter.
- Patients (or LAR) who are able to provide informed consent.
- Patients with previous total body photography images taken at least 3 years prior
Age in the registry: 30 years to - · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Memorial Sloan Kettering Basking Ridge (Consent Only) Coordinator of this site? Confirm its status | Basking Ridge | United States | Unknown status |
| Memorial Sloan Kettering Westchester (Consent only) Coordinator of this site? Confirm its status | Harrison | United States | Unknown status |
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.